NOVARTIND / NSE / Biotechnology & Drugs
Novartis India
1Y Price Trend
Key Information
Recommendations
Target High1,588.4
Target Low750
Target Mean0
Target Median0
Risk Metrics
Overall RiskHigh risk
Board Risk46.84
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Novartis India Ltd Hits Intraday Low Amid Price Pressure on 3 June 2026 Markets Mojo
Novartis India Ltd is Rated Hold Markets Mojo
Broad-Based Technical Strength Lifts Novartis India Ltd to 52-Week High of Rs 1462.5 Markets Mojo
Strong Momentum Meets Stretched Valuations as Novartis India Ltd Reaches All-Time High Markets Mojo
Strong Momentum Meets Stretched Valuations as Novartis India Ltd Reaches All-Time High Markets Mojo
Novartis India Appoints Gowree Gokhale as Independent Director scanx.trade
Novartis India FY26 Net Profit Declines; Dividend Nil scanx.trade
Novartis India Q4 FY26: Profit Slump and Margin Pressures Cloud Strong Revenue Growth Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026